Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001213900-16-016819
Filing Date
2016-09-15
Accepted
2016-09-15 17:07:09
Documents
1
Effectiveness Date
2016-09-15
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 7255
  Complete submission text file 0001213900-16-016819.txt   8515
Mailing Address DANDRIT BIOTECH A/S FRUEBJERGVEJ 3 BOX 62 2100 COPENHAGEN G7
Business Address DANDRIT BIOTECH A/S FRUEBJERGVEJ 3 BOX 62 2100 COPENHAGEN G7 45 39179840
DanDrit Biotech USA, Inc. (Filer) CIK: 0001527728 (see all company filings)

EIN.: 452259340 | State of Incorp.: DE | Fiscal Year End: 0630
Type: D | Act: 33 | File No.: 021-270777 | Film No.: 161887730
SIC: 2834 Pharmaceutical Preparations